Bohmann C, Rump L C, Schaible U, von Kügelgen I
Medizinische Universitätsklinik Freiburg, Innere Medizin IV, Germany.
Hypertension. 1995 Jun;25(6):1224-31. doi: 10.1161/01.hyp.25.6.1224.
The present study investigates sympathetic cotransmission and its alpha-adrenoceptor-mediated modulation in kidneys of spontaneously hypertensive rats (SHR, 12 to 14 weeks) and age-matched normotensive Wistar-Kyoto rats (WKY). In the presence of cocaine and corticosterone, renal nerve stimulation at 1 Hz (30 seconds) induced a greater outflow of norepinephrine in SHR (4.2 +/- 0.2 pmol/g kidney) than in WKY (3.0 +/- 0.2 pmol/g kidney). The alpha 2-adrenoceptor antagonist rauwolscine (0.01 to 1 mumol/L) increased the stimulation-induced norepinephrine outflow to a greater extent in SHR than in WKY. In contrast, the alpha 1-adrenoceptor antagonist prazosin (0.03 to 3 mumol/L) increased the stimulation-induced norepinephrine outflow to a greater extent in WKY than in SHR. This difference was not observed in the presence of the P1-purinoceptor antagonist 8-(p-sulfophenyl)theophylline (100 mumol/L). Stimulation at 4 Hz (30 seconds) induced an outflow of ATP (SHR, 12.7 +/- 3.3 pmol/g kidney; WKY, 16.7 +/- 2.1 pmol/g kidney; perfusion solution without cocaine and corticosterone). Prazosin (0.03 mumol/L) markedly reduced pressor responses to stimulation and inhibited the induced ATP outflow by 60% to 70%. When prazosin (0.03 mumol/L) was present, rauwolscine (0.1 mumol/L) increased the induced outflow of norepinephrine and ATP and markedly enhanced prazosin-resistant pressor responses. These pressor responses were abolished by the P2-purinoceptor antagonist suramin (300 mumol/L). The results demonstrate an increased alpha 2-adrenoceptor-mediated automodulation of norepinephrine release in SHR kidneys caused by increased intrasynaptic norepinephrine levels.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究调查了自发性高血压大鼠(SHR,12至14周龄)和年龄匹配的正常血压Wistar-Kyoto大鼠(WKY)肾脏中的交感神经共同传递及其α-肾上腺素能受体介导的调节。在存在可卡因和皮质酮的情况下,以1Hz(30秒)频率刺激肾神经,SHR(4.2±0.2pmol/g肾脏)中去甲肾上腺素的流出量比WKY(3.0±0.2pmol/g肾脏)更多。α2-肾上腺素能受体拮抗剂萝芙木碱(0.01至1μmol/L)在SHR中比在WKY中更大程度地增加了刺激诱导的去甲肾上腺素流出量。相反,α1-肾上腺素能受体拮抗剂哌唑嗪(0.03至3μmol/L)在WKY中比在SHR中更大程度地增加了刺激诱导的去甲肾上腺素流出量。在存在P1-嘌呤受体拮抗剂8-(对-磺基苯基)茶碱(100μmol/L)的情况下未观察到这种差异。以4Hz(30秒)频率刺激诱导了ATP的流出(SHR,12.7±3.3pmol/g肾脏;WKY,16.7±2.1pmol/g肾脏;灌注溶液中无可卡因和皮质酮)。哌唑嗪(0.03μmol/L)显著降低了对刺激的升压反应,并抑制诱导的ATP流出60%至70%。当存在哌唑嗪(0.03μmol/L)时,萝芙木碱(0.1μmol/L)增加了诱导的去甲肾上腺素和ATP流出量,并显著增强了对哌唑嗪耐药的升压反应。这些升压反应被P2-嘌呤受体拮抗剂苏拉明(300μmol/L)消除。结果表明,突触内去甲肾上腺素水平升高导致SHR肾脏中α2-肾上腺素能受体介导的去甲肾上腺素释放自动调节增加。(摘要截短于250字)